Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ravi Anand, MD
Newron Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Help Hospital
Vijayawada, Andhra Pradesh, India
Not, yet, recruiting - Masina Hospital Trust
Mumbai, Maharashtra, India
Recruiting - Ahana Hospitals Llp
Madurai, Tamil Nadu, India
Recruiting - Udyan Health Care
Lucknow, Uttar Pradesh, India
Recruiting - Seth Sukhlal Karnani Memorial Hospital
Kolkata, West Bengal, India
Not, yet, recruiting
- Ucla Dgsom, Ucla Health, Ucla Semel Institute
Los Angeles, California, United States
Suspended - University of Miami, Miller School of Medicine; Jackson Behavioral Health Hospital
Miami, Florida, United States
Suspended - Grady Behavioral Health Center, -Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine
Atlanta, Georgia, United States
Suspended - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
Suspended - Manhattan Psychiatric Center, the Nathan Kline Institute for Psychiatric Research
New York, New York, United States
Suspended
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Jan 2026
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 4 Jun 2026
- Registered enrollment
- 400
- Registry id
- NCT07184619
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.